Skip to main content

Stream every public session from the 27th annual Global Conference right here on our website.

Can Cell and Gene Therapies Be Made Cheaper?

2023 Future of Health Summit

Can Cell and Gene Therapies Be Made Cheaper?

Monday, November 6, 2023
01:30 PM - 02:30 PM EST
Salamander Washington DC - Gallery A

Cell and gene therapies were set to take the market by storm and transform the treatment landscape. But more than five years out from the first approval in 2017, fewer cell and gene therapies have been approved in the US than expected. The cost of developing and manufacturing these transformative therapies remains astronomical and has brought into question their commercial viability. Why have advances in science and technology not translated into efficiencies in this area? What are the opportunities and challenges to lowering the costs to develop cell and gene therapies, and how low can it really go?

Kevin Davies
Executive Editor, The CRISPR Journal; Author, Editing Humanity
Mike Lehmicke
Senior Vice President, Science and Industry Affairs, Alliance for Regenerative Medicine
Peter Marks
Director, Center for Biologics Evaluation and Research, US Food and Drug Administration
Nabiha Saklayen
Co-Founder and CEO, Cellino
Ran Zheng
CEO, Landmark Bio